The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $2.60

Today's change0.00 0.00%
Updated August 21 3:56 PM EDT. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $2.60

Today's change0.00 0.00%
Updated August 21 3:56 PM EDT. Delayed by at least 15 minutes.

aTyr Pharma Inc unchanged

aTyr Pharma Inc closed unchanged Monday sitting at (U.S.)$2.60. Shares have lost 20.00% over the last five days, but have gained 20.93% over the last year to date. This security has underperformed the S&P 500 by 33.36% during the last year.

Key company metrics

  • Open(U.S.) $2.55
  • Previous close(U.S.) $2.60
  • High(U.S.) $2.75
  • Low(U.S.) $2.46
  • Bid / Ask(U.S.) $2.55 / (U.S.) $2.60
  • YTD % change+20.93%
  • Volume50,099
  • Average volume (10-day)60,973
  • Average volume (1-month)40,502
  • Average volume (3-month)32,709
  • 52-week range(U.S.) $2.10 to (U.S.) $4.45
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.19
Updated August 21 3:56 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense12131314
Selling / general / administrative3433
Research & development89910
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0--
Other operating expenses, total--------
Operating income-12-13-13-14
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-12-13-13-14
Income after tax-12-13-13-14
Income tax, total----0--
Net income-12-13-13-14
Total adjustments to net income----00
Net income before extra. items-12-13-13-14
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-13-13-14
Inc. avail. to common incl. extra. items-12-13-13-14
Diluted net income-12-13-13-14
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.51-0.56-0.53-0.58
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.51-0.56-0.53-0.58